Adiukwu, Frances N.
Yocum, Anastasia K.
Wright, Brittany M.
Gesler, Ian
McInnis, Melvin G.
Funding for this research was provided by:
Heinz C Prechter Bipolar Research Fund
Richard Tam Foundation
National Institutes of Health
Article History
Received: 29 March 2024
Accepted: 1 August 2024
First Online: 7 August 2024
Declarations
:
: The IRBMED, HUM00227871, approved secondary use of the electronic medical record data, which includes Waiver of Informed Consent (45 CFR 46.116), for secondary use of the electronic medical record data. This study is in accordance of US Department of Health and Human Services, 45CFR Part 46, Common Rule Signatory.
: MGM has consulted for Janssen and Otsuka Pharmaceuticals and received research support from Janssen. All other authors report no conflicts related to this work.